awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38831491-4C7564A9-58F9-4EC9-8947-50C000E65F7E
Q38831491-4C7564A9-58F9-4EC9-8947-50C000E65F7E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38831491-4C7564A9-58F9-4EC9-8947-50C000E65F7E
Adjuvant Therapy of Resected Non-small Cell Lung Cancer: can We Move Forward?
P2860
Q38831491-4C7564A9-58F9-4EC9-8947-50C000E65F7E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38831491-4C7564A9-58F9-4EC9-8947-50C000E65F7E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
304b93219fdd1293045c36454d7cdfd9caae4b76
P2860
Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial.